Australian IT Investments

Australian IT Investments is a private Australian investment company and holding firm that specializes in the life sciences and biotechnology sectors. The company is primarily known for being the largest and a long-term strategic shareholder in Starpharma Holdings Limited, a prominent Australian biopharmaceutical company. Through its significant stake in Starpharma, Australian IT Investments is indirectly involved in the development of dendrimer-based therapeutic products and the DEP drug delivery platform. The firm serves as the primary investment vehicle for the Shiff family, who were instrumental in the founding and early development of the Australian biotech industry. While the company does not maintain its own internal drug pipeline, its investment focus is centered on innovative healthcare technologies and pharmaceutical advancements. It remains a key influential entity within the Australian life sciences investment landscape.